235 results on '"Kremens, B"'
Search Results
2. Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
3. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
4. Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival
5. Immune neutropenia mimicking graft failure after granulocyte transfusions and allogeneic stem cell transplantation in a child severe congenital neutropenia: AB82
6. Allo-SCT using BU, CY and melphalan for children with AML in second CR
7. Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report
8. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
9. HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IS A THERAPEUTIC OPTION IN PATIENTS WITH REFRACTORY ACQUIRED SEVERE APLASTIC ANEMIA: A SURVEY BY THE SEVERE APLASTIC ANEMIA WORKING PARTY (SAAWP) AND PAEDIATRIC DISEASES WORKING PARTY (PDWP) OF THE EU: WP-O007
10. CLINICAL IMPACT OF POST-TRANSPLANT CHIMERISM MONITORING IN CD33/34 BONE MARROW SUBPOPULATIONS AND WHOLE PERIPHERAL BLOOD IN PEDIATRIC AML: PROSPECTIVE COMPARISON OF HIGHLY SENSITIVE REAL TIME SEQUENCE POLYMORPHISM PCR VERSUS GOLD-STANDARD STR-PCR: PH-O097
11. Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation
12. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood
13. Metalloenzymes
14. Metallothionein enzymes
15. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children
16. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia
17. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective
18. Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS)
19. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma
20. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma
21. Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases
22. Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells
23. Impact of real-time sequence polymorphism (SP)-qPCR on post-transplant monitoring of haematopoietic chimerism in paediatric myelodysplastic syndrome: P562
24. Intensified pre-emptive immunotherapy in childhood acute myeloid leukaemia patients showing evidence of mixed chimerism after allogeneic stem cell transplantation: O171
25. Post-transplant monitoring of haematopoietic chimerism in childhood ALL: competitive STR-PCR versus real-time sequence polymorphism (SP)-PCR: O425
26. Epstein-Barr virus induced lymphoproliferative disorders in children following haematopoietic stem cell transplantation. A survey of the German/Austrian paediatric stem cell registry
27. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation
28. Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia
29. Vaccination with HCMV pp65-loaded DCs following allo-SCT: V316
30. Harvesting of Peripheral Blood Stem Cells in Children with use of the Amicus Blood Cell Separator
31. Impact of high resolution HLA-A,B,C donor-recipient matching on clinical outcome of allogeneic hematopoietic stem cell transplantation (hsct) from unrelated donors: 31
32. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
33. Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia
34. Loss of blood pressure control on withdrawal of fluconazole during nifedipine therapy
35. Erratum: High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma
36. Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004
37. Thanatophoric dysplasia with cloverleaf-skull: Case report and review of the literature
38. A new conditioning regimen for patients with refractory anemia and congenital disorders
39. MULTIVARIATE ANALYSIS OF RISK FACTORS IN STAGE IV NEUROBLASTOMA PATIENTS OVER THE AGE OF ONE YEAR TREATED WITH MEGATHERAPY AND STEM CELL TRANSPLANTATION: A REPORT FROM THE EUROPEAN BONE MARROW TRANSPLANTATION SOLID TUMOR REGISTRY
40. Nephroblastom.
41. Grundlagen der pädiatrischen Uroonkologie.
42. NON TUMORAL DEATH (NTD) AFTER MEGATHERAPY (MGT) FOR NEUROBLASTOMA (NBL). THE EBMT EXPERIENCE
43. ADVERSE PROGNOSTIC FACTORS IN STAGE 4 NEUROBLASTOMA (NBL) OVER ONE YEAR OF AGE. A REPORT FROM THE EUROPEAN BONE MARROW TRANSPLANTATION SOLID TUMOR REGISTRY
44. ANALYSIS OF THE EUROPEAN EXPERIENCE WITH MEGATHERAPY (MGT) AND BONE MARROW TRANSPLANTATION (BMT) IN NEUROBLASTOMA (NBL). A FINAL REPORT OF THE EBMT SOLID TUMOR REGISTRY
45. Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia.
46. Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML - Results from Study AML-BFM 2004.
47. Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000.
48. Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I.
49. DIFFERENTIAL DIAGNOSIS OF CHOLESTASIS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN.
50. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.